Prothrombin Time Concept

subject area of

• "Therapeutic range" for oral anticoagulant therapy.  Journal Articles
• A Comparison of Lyophilized Artificially Depleted Plasmas and Lyophilized Plasmas From Patients Receiving Warfarin in Correcting for Coagulometer Effects on International Normalized Ratios  Journal Articles
• A Novel Whole Blood Capillary Technic for Measuring the Prothrombin Time  Journal Articles
• A novel congenital haemostatic defect  Journal Articles
• A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty  Journal Articles
• AUSTRALIAN MULTICENTRE TRIAL OF STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION  Journal Articles
• Agreements Between the Prothrombin Times of Blood Treated In Vitro with Heparinase During Cardiopulmonary Bypass (CPB) and Blood Sampled After CPB and Systemic Protamine  Journal Articles
• Anticoagulant response after dalteparin overdose  Journal Articles
• Anticoagulants in Venous Thromboembolism  Journal Articles
• Antithrombotic Activity of the Novel Oral Anticoagulant, Tecarfarin [Sodium 3-[4-((1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yloxy) carbonyl) benzyl]-2-oxo-2H-chromen-4-olate] in Animal Models  Journal Articles
• Antithrombotic Therapy in Patients With Mechanical and Biological Prosthetic Heart Valves  Journal Articles
• Approaches to investigating common bleeding disorders: An evaluation of North American coagulation laboratory practices  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism  Journal Articles
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism  Journal Articles
• Capillary Whole Blood Monitoring of Oral Anticoagulants in Children in Outpatient Clinics and the Home Setting  Journal Articles
• Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit?  Journal Articles
• Changes in coagulation factor activity and content of di(2‐ethylhexyl)phthalate in frozen plasma units during refrigerated storage for up to five days after thawing  Journal Articles
• Coagulation Assays  Journal Articles
• Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents  Journal Articles
• Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers  Journal Articles
• Complications of long‐term anticoagulation  Journal Articles
• Confusion Over the Therapeutic Range for Monitoring Oral Anticoagulant Therapy in North America  Journal Articles
• Critical Values in the Coagulation Laboratory Results of a Survey of the North American Specialized Coagulation Laboratory Association  Journal Articles
• Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential  Journal Articles
• Development of the human coagulation system in the full-term infant  Journal Articles
• Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation  Journal Articles
• Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis  Journal Articles
• Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fraction  Journal Articles
• Do Coagulation Screening Tests Detect Increased Generation of Thrombin and Plasmin in Sick Newborn Infants?  Journal Articles
• Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure  Journal Articles
• Effects of sodium warfarin administered during pregnancy in mice  Journal Articles
• EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis  Journal Articles
• Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant  Journal Articles
• Evaluation of the phospholipid-rich dilute Russell's viper venom assay to monitor oral anticoagulation in patients with lupus anticoagulant.  Journal Articles
• Fetal Effects of Coumadin Administered During Pregnancy  Journal Articles
• HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions  Journal Articles
• Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.  Journal Articles
• INR reporting in Canadian medical laboratories  Journal Articles
• INR reporting in Canadian medical laboratories. Thrombosis Interest Group of Canada.  Journal Articles
• Idiopathic gangrene in African children.  Journal Articles
• Inadequate monitoring of warfarin dosage [letter] [see comments]  Journal Articles
• Influenza Vaccination and Vitamin K Antagonist Treatment  Journal Articles
• Inhibition of Warfarin Activity by Ribavirin  Journal Articles
• International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants  Journal Articles
• Is the dose of warfarin prescribed by American physicians unnecessarily high?  Journal Articles
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Journal Articles
• Laboratory Monitoring of Oral Vitamin K Anticoagulation  Journal Articles
• Laboratory monitoring of oral anticoagulant therapy.  Journal Articles
• Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients  Journal Articles
• Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin  Journal Articles
• Mechanism of Action and Monitoring of Anticoagulants  Journal Articles
• Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH  Journal Articles
• Monitoring the anticoagulant effect after a massive rivaroxaban overdose  Journal Articles
• Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate  Journal Articles
• Multicentric Evaluation of a New PT Reagent Based on Recombinant Human Tissue Factor and Synthetic Phospholipids  Journal Articles
• Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor  Journal Articles
• New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF  Journal Articles
• New developments in laboratory diagnosis and monitoring  Journal Articles
• Optimal Therapeutic Range for Oral Anticoagulants  Journal Articles
• Optimal intensity and monitoring warfarin  Journal Articles
• Optimal therapeutic range for oral anticoagulants.  Journal Articles
• Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms  Journal Articles
• Oral Anticoagulants  Journal Articles
• Oral anticoagulant therapy. Urgent need for standardization.  Journal Articles
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Journal Articles
• Perioperative Management of Patients Receiving Oral Anticoagulants  Journal Articles
• Perioperative Management of Patients Receiving Oral Anticoagulants  Journal Articles
• Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation  Journal Articles
• Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery  Journal Articles
• Prolonged Prothrombin Time and Partial Thromboplastin Time in Disseminated Intravascular Coagulation not Due to Deficiency of Factors V and VIII  Journal Articles
• Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation  Journal Articles
• RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT  Journal Articles
• RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis‐induced coagulopathy than fibrin‐related markers: Response to the Letter‐to‐the‐Editor by Dr Wada  Journal Articles
• RESOLUTION OF ACUTE MASSIVE PULMONARY EMBOLISM AFTER PULMONARY ARTERIAL INFUSION OF STREPTOKINASE  Journal Articles
• Rapid diagnosis of coagulopathies from vitamin K deficiency in a consecutive case cohort evaluated by comparative assessment of factor II by one stage assays with prothrombin time versus Ecarin reagents  Journal Articles
• Reliability of the international normalized ratio for monitoring the induction phase of warfarin: Comparison with the prothrombin time ratio  Journal Articles
• Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban  Journal Articles
• Reversal of direct oral anticoagulants: a practical approach  Journal Articles
• Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy  Journal Articles
• Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers  Journal Articles
• Solving the mystery of excessive warfarin-induced bleeding: A personal historical perspective  Journal Articles
• Substandard monitoring of warfarin in North America. Time for change  Journal Articles
• The Effect of Temperature Variation In Vitro on Platelet-Leukocyte Interactions and Individual Prothrombotic Potential  Journal Articles
• The Value of Plasma Calibrants in Correcting Coagulometer Effects on International Normalized Ratios:An International Multicenter Study  Journal Articles
• The historical origins of modern international normalized ratio targets  Journal Articles
• The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor  Journal Articles
• The international normalized ratio. A guide to understanding and correcting its problems  Journal Articles
• The optimal intensity of oral anticoagulant therapy  Journal Articles
• The rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B release  Journal Articles
• The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by “true” heparin-induced thrombocytopenia  Journal Articles
• Therapeutic Range for the Control of Oral Anticoagulant Therapy  Journal Articles
• Thrombin Generation in Newborn Plasma Is Critically Dependent on the Concentration of Prothrombin  Journal Articles
• Thrombin activation rate constant: One-stage chromogenic assay for the extrinsic system  Journal Articles
• Thrombin generation, ProC(®)Global, prothrombin time and activated partial thromboplastin time in thawed plasma stored for seven days and after methylene blue/light pathogen inactivation.  Journal Articles
• Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics  Journal Articles
• Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis  Journal Articles
• Withdrawal of warfarin after deep vein thrombosis  Journal Articles
• “Therapeutic Range” for Oral Anticoagulant Therapy  Journal Articles